Keywords: Tumors (Pre-Treatment), Tumor
Motivation: To investigate the efficacy of MRI features and CD8+ T cells in predicting risk stratification for meningioma recurrence.
Goal(s): To develop a reliable nomogram incorporating MRI features and CD8+ T cells to predict meningioma recurrence.
Approach: Conventional MRI features, ADC histogram parameters, and CD8+ T cells were recorded and compared. This model was the first to combine clinical, imaging, and TME data to predict meningioma recurrence.
Results: The ADCp1 and CD8+ T cells as predictive variables for meningioma recurrence and patients with low ADCp1 or CD8+ T cell counts had higher recurrence rates than those with high ADCp1 or CD8+ T cell counts.
Impact: The findings will improve prognostic accuracy for patients with meningioma and potentially allow for targeted treatment of individuals who have the recurrent form.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords